Experian plc (LON:EXPN - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 2,714.09 and traded as high as GBX 2,906.12. Experian shares last traded at GBX 2,858, with a volume of 2,196,041 shares traded.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 4,600 price objective on shares of Experian in a research note on Thursday, May 21st. Stifel Nicolaus reissued a "buy" rating and issued a GBX 4,400 target price on shares of Experian in a research note on Wednesday, May 20th. Royal Bank Of Canada reissued an "outperform" rating and issued a GBX 4,000 target price on shares of Experian in a research note on Friday, July 17th. Citigroup cut Experian to a "buy" rating in a report on Monday, July 20th. Finally, UBS Group restated a "buy" rating and issued a GBX 3,700 price target on shares of Experian in a research report on Monday, May 18th. Six equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of GBX 4,087.33.
View Our Latest Stock Analysis on EXPN
Experian Price Performance
The stock has a market cap of £25.27 billion, a PE ratio of 17.49, a price-to-earnings-growth ratio of 2.48 and a beta of 0.85. The stock's fifty day moving average is GBX 2,836.96 and its 200-day moving average is GBX 2,714.09. The company has a debt-to-equity ratio of 100.36, a current ratio of 0.85 and a quick ratio of 0.76.
Experian declared that its board has authorized a stock repurchase plan on Wednesday, July 1st that permits the company to repurchase $0.00 in outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.
Experian Company Profile
(
Get Free Report)
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and platforms. We also assist millions of people to realise their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and to innovate.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Experian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Experian wasn't on the list.
While Experian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.